No evidence of RET germline mutations in familial pituitary adenoma
No evidence of RET germline mutations in familial pituitary adenoma
Pituitary adenomas are common in the general population. Although most of them are sporadic, some occur in a familial setting. In familial pituitary adenoma patients it is common that no germline defects are found after screening of aryl hydrocarbon receptor interacting protein (AIP) and other genes known to underlie the condition, suggesting the existence of yet unknown predisposition genes. Recently, the RET proto-oncogene was found to be a novel in vivo interaction partner of AIP in the pituitary gland. Here, we have screened patients from 16 AIP mutation negative (AIPmut-) pituitary adenoma families for RET germline mutations to assess whether RET could play a role in pituitary adenoma predisposition, similar to AIP. We found five novel germline RET changes: one in RET Exon 4 and the rest in noncoding regions of RET. Two changes, c.1560*G>A and -1285G>A, were segregated in affected family members. We also analyzed the RET region with enhancer element locator (EEL) to identify RET regulatory elements, and to see whether the changes resided in these. None of the variants mapped to the regions predicted by EEL. Expression of RET was examined in ten AIPmut- and seven AIP mutation positive (AIPmut+) somatotropinomas by immunohistochemistry, with a trend showing reduced expression in the latter (P=0.05). We conclude that the RET variants are presumably not related to pituitary adenoma predisposition, although reduced RET expression may play a role in AIP-related genesis of somatotropinomas.
1-8
Heliövaara, Elina
c5d4240e-9004-4463-9b71-89b5c52acded
Tuupanen, Sari
f2522a59-f70b-4d0f-94d5-ba1c69b4d587
Ahlsten, Manuel
a5cd7bfc-2f21-44ba-a732-b504410132de
Hodgson, Shirley
a9f6b2c4-f329-40b5-8b07-a74b3fdd1a0c
De Menis, Ernesto
65fbfd88-9bb8-4f26-ad0a-c8707269c02a
Kuismin, Outi
1ac0c021-6ec6-4543-b2a5-4760713946bf
Izatt, Louise
5d6201a8-8a56-4923-ac9d-75dca6be0a40
Gardner, R. J.Mc Kinlay
ce4cdb4e-5b61-4416-bbce-15a177944d8c
Gundogdu, Sadi
edf4d71b-8162-4483-9082-7aa14e4e8bac
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Arola, Johanna
8309193f-65d6-4817-af95-c4cded184cee
Tuomisto, Anne
bf001fb7-89aa-4cb7-bb86-c27b01bd4f5b
Mäkinen, Markus
1274ebed-9e89-4344-bb7e-de4316713ff6
Karhu, Auli
b0ebd43a-6a3b-477c-97e2-39bdca785073
Aaltonen, Lauri A.
1f26d3d5-721c-4652-8a77-95debd33275a
1 February 2011
Heliövaara, Elina
c5d4240e-9004-4463-9b71-89b5c52acded
Tuupanen, Sari
f2522a59-f70b-4d0f-94d5-ba1c69b4d587
Ahlsten, Manuel
a5cd7bfc-2f21-44ba-a732-b504410132de
Hodgson, Shirley
a9f6b2c4-f329-40b5-8b07-a74b3fdd1a0c
De Menis, Ernesto
65fbfd88-9bb8-4f26-ad0a-c8707269c02a
Kuismin, Outi
1ac0c021-6ec6-4543-b2a5-4760713946bf
Izatt, Louise
5d6201a8-8a56-4923-ac9d-75dca6be0a40
Gardner, R. J.Mc Kinlay
ce4cdb4e-5b61-4416-bbce-15a177944d8c
Gundogdu, Sadi
edf4d71b-8162-4483-9082-7aa14e4e8bac
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Arola, Johanna
8309193f-65d6-4817-af95-c4cded184cee
Tuomisto, Anne
bf001fb7-89aa-4cb7-bb86-c27b01bd4f5b
Mäkinen, Markus
1274ebed-9e89-4344-bb7e-de4316713ff6
Karhu, Auli
b0ebd43a-6a3b-477c-97e2-39bdca785073
Aaltonen, Lauri A.
1f26d3d5-721c-4652-8a77-95debd33275a
Heliövaara, Elina, Tuupanen, Sari, Ahlsten, Manuel, Hodgson, Shirley, De Menis, Ernesto, Kuismin, Outi, Izatt, Louise, Gardner, R. J.Mc Kinlay, Gundogdu, Sadi, Lucassen, Anneke, Arola, Johanna, Tuomisto, Anne, Mäkinen, Markus, Karhu, Auli and Aaltonen, Lauri A.
(2011)
No evidence of RET germline mutations in familial pituitary adenoma.
Journal of Molecular Endocrinology, 46 (1), .
(doi:10.1677/JME-10-0052).
Abstract
Pituitary adenomas are common in the general population. Although most of them are sporadic, some occur in a familial setting. In familial pituitary adenoma patients it is common that no germline defects are found after screening of aryl hydrocarbon receptor interacting protein (AIP) and other genes known to underlie the condition, suggesting the existence of yet unknown predisposition genes. Recently, the RET proto-oncogene was found to be a novel in vivo interaction partner of AIP in the pituitary gland. Here, we have screened patients from 16 AIP mutation negative (AIPmut-) pituitary adenoma families for RET germline mutations to assess whether RET could play a role in pituitary adenoma predisposition, similar to AIP. We found five novel germline RET changes: one in RET Exon 4 and the rest in noncoding regions of RET. Two changes, c.1560*G>A and -1285G>A, were segregated in affected family members. We also analyzed the RET region with enhancer element locator (EEL) to identify RET regulatory elements, and to see whether the changes resided in these. None of the variants mapped to the regions predicted by EEL. Expression of RET was examined in ten AIPmut- and seven AIP mutation positive (AIPmut+) somatotropinomas by immunohistochemistry, with a trend showing reduced expression in the latter (P=0.05). We conclude that the RET variants are presumably not related to pituitary adenoma predisposition, although reduced RET expression may play a role in AIP-related genesis of somatotropinomas.
This record has no associated files available for download.
More information
Published date: 1 February 2011
Identifiers
Local EPrints ID: 469446
URI: http://eprints.soton.ac.uk/id/eprint/469446
ISSN: 0952-5041
PURE UUID: c399c49e-fc46-4801-bd98-ca0c7c3fdab6
Catalogue record
Date deposited: 14 Sep 2022 16:52
Last modified: 17 Mar 2024 02:54
Export record
Altmetrics
Contributors
Author:
Elina Heliövaara
Author:
Sari Tuupanen
Author:
Manuel Ahlsten
Author:
Shirley Hodgson
Author:
Ernesto De Menis
Author:
Outi Kuismin
Author:
Louise Izatt
Author:
R. J.Mc Kinlay Gardner
Author:
Sadi Gundogdu
Author:
Johanna Arola
Author:
Anne Tuomisto
Author:
Markus Mäkinen
Author:
Auli Karhu
Author:
Lauri A. Aaltonen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics